The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Tecentriq
Device/Product Name
Tecentriq
Active ingredients
Atezolizumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2019-05906-1-4
Submission Type
Extension of indications
Decision
Withdrawn